Publications
23
Citations
141
Est. group size
—
Recurring co-author estimate
Active years
28
Publishing since 1998
Guang-Sheng Lei conducts biomedical research spanning several areas of infectious disease and cellular biology. Published work includes studies on respiratory infections such as Pneumocystis pneumonia and diagnostics related to SARS-CoV-2 (the virus that causes COVID-19), as well as laboratory research on liver cell processes like lipophagy (the breakdown of fat within cells). The work combines clinical/microbiological topics with molecular cell biology.
After a gap around 2018-2020, publication activity has grown over recent years, averaging about 2.6 papers per year over the last five years and peaking in 2024.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Ethanol-triggered Lipophagy Requires SQSTM1 in AML12 Hepatic Cells
Scientific Reports · 2017
- Ethanol-triggered Lipophagy Requires SQSTM1 in AML12 Hepatic Cells
PMC · 2017
- Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
PMC · 2016
- Microbiology Spectrum×2
- Pediatric and Developmental Pathology×2
- PMC×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Proceedings of IMPRS×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile